AbCellera, Gilead collaborate for new multi-year, multi-target antibody discovery EP News Bureau Apr 1, 2021 Expanded collaboration includes an eight-target discovery partnership leveraging AbCellera’s entire technology stack
FairJourney Biologics, IONTAS enter antibody discovery pact with Pandion Therapeutics EP News Bureau Nov 23, 2020 Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to…
